Vers une prise en charge histoguidée des CBNPC

G. Milano; J. Bennouna; D. Planchard

doi:10.1016/S0761-8425(09)73535-1

Vers une prise en charge histoguidée des CBNPC

G. Milano, J. Bennouna, D. Planchard

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

2 Citations (Scopus)

Résumé

Currently the management of non-small cell lung cancer with first line chemotherapy is dependent on the histology. The growth of morbid anatomy laboratories and molecular biology, alongside the rapid expansion of new therapies, is necessary for the selection of patients according to predictive criteria of efficacy and tolerance, allowing definition of a made to measure treatment.

Titre traduit de la contribution	Towards a histologically guided management for NSCLC
langue originale	Français
Pages (de - à)	1097-1106
Nombre de pages	10
journal	Revue des Maladies Respiratoires
Volume	26
Numéro de publication	10
Les DOIs	https://doi.org/10.1016/S0761-8425(09)73535-1
état	Publié - 1 janv. 2009

mots-clés

Histology
Non-small cell lung cancer
Predictive factors
Targeted therapies

Accès au document

10.1016/S0761-8425(09)73535-1

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{d7bd1e01826a441dacd8af03329ce1e3,

title = "Vers une prise en charge histoguid{\'e}e des CBNPC",

abstract = "Currently the management of non-small cell lung cancer with first line chemotherapy is dependent on the histology. The growth of morbid anatomy laboratories and molecular biology, alongside the rapid expansion of new therapies, is necessary for the selection of patients according to predictive criteria of efficacy and tolerance, allowing definition of a made to measure treatment.",

keywords = "Histology, Non-small cell lung cancer, Predictive factors, Targeted therapies",

author = "G. Milano and J. Bennouna and D. Planchard",

year = "2009",

month = jan,

day = "1",

doi = "10.1016/S0761-8425(09)73535-1",

language = "Fran{\c c}ais",

volume = "26",

pages = "1097--1106",

journal = "Revue des Maladies Respiratoires",

issn = "0761-8425",

number = "10",

}

TY - JOUR

T1 - Vers une prise en charge histoguidée des CBNPC

AU - Milano, G.

AU - Bennouna, J.

AU - Planchard, D.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Currently the management of non-small cell lung cancer with first line chemotherapy is dependent on the histology. The growth of morbid anatomy laboratories and molecular biology, alongside the rapid expansion of new therapies, is necessary for the selection of patients according to predictive criteria of efficacy and tolerance, allowing definition of a made to measure treatment.

AB - Currently the management of non-small cell lung cancer with first line chemotherapy is dependent on the histology. The growth of morbid anatomy laboratories and molecular biology, alongside the rapid expansion of new therapies, is necessary for the selection of patients according to predictive criteria of efficacy and tolerance, allowing definition of a made to measure treatment.

KW - Histology

KW - Non-small cell lung cancer

KW - Predictive factors

KW - Targeted therapies

UR - http://www.scopus.com/inward/record.url?scp=74249116637&partnerID=8YFLogxK

U2 - 10.1016/S0761-8425(09)73535-1

DO - 10.1016/S0761-8425(09)73535-1

M3 - Article

AN - SCOPUS:74249116637

SN - 0761-8425

VL - 26

SP - 1097

EP - 1106

JO - Revue des Maladies Respiratoires

JF - Revue des Maladies Respiratoires

IS - 10

ER -